IL10 and atherosclerosis: Furthermore, in the estrogen replacement and atherosclerosis (ERA) study, an elevated baseline level of IL-10 was correlated with cardiovascular outcomes in post-menopausal women with angiographically proven coronary artery disease (n = 309, follow-up of 3.2 years) [12].